Financing the Next Wave of Aerospace and Defense Technology: New Capital, New Exit Strategies

Skadden Publication / National Security: Aerospace and Defense

P. Michelle Gasaway David A. Niemeyer Leila B. Sayegh

Executive Summary

  • What’s new: A broader capital toolkit is giving aerospace and defense companies more ways to fund growth alongside venture equity, while strategic buyers are pursuing emerging technologies, specialized talent and intellectual property.
  • Why it matters: Aerospace and defense companies are capital-intensive and must invest heavily long before generating meaningful revenue. The right capital mix can help manage dilution and support growth, but financing terms can also narrow future options.
  • What to do next: Developing financing and exit strategies together may be prudent. Founders, executives and boards should consider reviewing the capital structure and investor and lender rights, matching funding to business milestones and identifying constraints before they limit the next financing or strategic transaction.

__________

The Return of Capital-Intensive Innovation

The aerospace and defense (A&D) sector is reviving a financing model that looks very different from the model that characterized the last decade of venture investing, when investment focused predominantly on asset-light businesses that could scale rapidly with modest upfront investment.

A&D businesses, which are seeing an increase in venture capital funding, have different financing needs. These businesses, which include those in defense technology, advanced manufacturing, aerospace, robotics and semiconductors, are capital-intensive and must invest heavily in hardware, engineering, manufacturing capacity, research and development, testing and certification long before they generate meaningful revenue.

A&D’s financing model resembles the model used when venture capital firms funded Silicon Valley’s early semiconductor companies alongside government programs in need of custom chips and other hardware.

Today’s A&D financing, however, operates on a different scale, requiring significantly more capital and longer execution timelines. Meeting these demands presents challenges but also offers financing opportunities that can augment and complement foundational venture capital investment.

To overcome these challenges, A&D companies and investors can look to a broader capital toolkit that includes strategic investments, asset-based lending, secured debt, government-backed lending programs and other forms of nondilutive or less-dilutive capital in addition to traditional venture equity. For companies building capital-intensive technologies, the question is not only how much equity to raise, but how to combine options to reach the next milestone, taking into account timing, life cycle, risk, and future financing and exit plans.

At the same time, acquisition strategies are evolving as established defense contractors and other strategic buyers seek access to emerging technologies, specialized engineering talent and differentiated intellectual property (IP). The result is a changing financing and M&A landscape.

Rethinking the Capital Stack

Venture equity remains foundational, but it can work alongside other potential capital solutions. Because A&D businesses require so much capital upfront, founders and early investors can face massive dilution, particularly if they cannot yet make a compelling case for rapid growth and valuations are not keeping pace with capital requirements. Where a company has financeable assets, contracted revenue or a credible path to repayment, options such as asset-based lending, secured debt and government-backed financing can offer benefits that aren’t always available when every aspect of the business is funded with venture equity.

Strategic equity can enhance commercial credibility and provide longer-term capital. Strategic equity can complement traditional venture financing, particularly in later rounds to fund scale-up phases, provide market validation and secure long-term commercial and collaboration agreements. As compared to traditional venture equity, strategic equity can take a longer-term view, with the objective being to secure a vital commercial capability rather than a liquidity event within the fund’s life cycle.

However, these different objectives may lead strategic investors to seek rights beyond those typically granted to venture investors in order to align their equity rights with their long-term commercial relationships. These can include longer-term board representation rights or particular consent rights, limitations on investments from competitors of the strategic investor, additional rights on future financings and additional equity tied to commercial milestones.

Asset-based lending can turn assets into financing capacity. Unlike traditional cash-flow-based lending, where borrowing capacity is often constrained by leverage multiples tied to EBITDA (earnings before interest, taxes, depreciation and amortization), asset-based lending generally determines availability by reference to a borrowing base calculated against eligible collateral. As a result, companies with substantial assets but relatively modest EBITDA may be able to access meaningful debt capacity without relying exclusively on traditional leverage metrics.

Asset-based lenders lend against eligible assets, such as accounts receivable, inventory and, in some cases, equipment. When negotiating these facilities, lenders evaluate collateral quality and eligibility conditions, advance rates, customer concentration, collection timing and the borrower’s ability to satisfy borrowing-base and reporting requirements. It is important to note that early-stage businesses may have limited eligible receivables or inventory, and specialized equipment can be difficult to value or liquidate. In addition, for companies with government or commercial contracts, receivables can — depending on the contract’s terms — provide liquidity as performance and billing milestones are achieved.

However, government receivables often present their own unique complexities, which need to be carefully reviewed and negotiated. Asset-based financing is therefore not a universal substitute for equity, but it becomes increasingly useful as a company’s asset and revenue profiles mature.

Equipment financing can help fund capital-intensive growth. A&D companies often must invest heavily in specialized machinery and manufacturing infrastructure long before the corresponding revenue materializes. Rather than funding these expenditures entirely with equity, companies may be able to leverage the equipment itself as collateral to obtain financing. Common structures include equipment term loans, equipment leases and sale-leaseback transactions, which can allow companies to finance new purchases or unlock liquidity from existing assets while preserving equity capital for other growth initiatives. Lenders under these types of facilities will evaluate the equipment’s value, useful life, resale market and degree of specialization, which may affect the amount of financing available.

Venture debt and other secured debt can bridge the gap between development and scale. Venture debt and other secured credit facilities can extend the runway between equity rounds or fund a specific growth initiative. Depending on the structure, they may involve liens on substantially all assets, financial or operational covenants, limits on additional debt and sometimes equity-linked features. For an A&D business, IP may represent a significant component of enterprise value and collateral, but granting lenders liens on IP can raise important considerations. Borrowers must balance providing lenders with sufficient collateral protection against preserving the flexibility to license technology, enter strategic partnerships and secure future financing. Accordingly, the scope of any lien, the treatment of after-acquired assets, permitted licenses, existing investor rights and intercreditor arrangements should be addressed early.

Government-backed financing may offer another source of capital for companies that can meet eligibility and other requirements. Government-backed loans and similar arrangements may provide access to longer repayment periods, matching of funds or financing terms that are difficult to obtain in the private credit market. They can be particularly relevant for businesses investing in domestic production capacity, industrial infrastructure or other strategically important capabilities. However, in addition to typical debt covenants, government-backed loans and project financing may involve the issuance of equity in the company and may require the company to comply with eligibility criteria, restrictions on the use of proceeds, minimum additional equity funding requirements, reporting obligations, and requirements relating to ownership and control of the company or its assets.

Importantly, these financing strategies are not mutually exclusive. A company may, for example, maintain an asset-based revolving credit facility secured by accounts receivable and inventory alongside a separate equipment term loan or lease facility secured by specialized machinery. By layering complementary financing products, companies can potentially increase aggregate borrowing capacity while matching different sources of capital to specific assets and funding needs. Such arrangements require careful consideration of collateral allocation, lien priorities, intercreditor arrangements and restrictions on additional indebtedness. As A&D companies look to scale, the goal should be to develop a capital structure that evolves with the business, with each source of capital supporting the company’s stage, risk profile, financing needs and long-term strategic objectives.

The Exit Playbook Is Also Changing

Venture-backed businesses have traditionally aimed for an IPO. An IPO is most attractive for companies with outsized valuations or significant growth prospects and substantial ongoing capital needs, particularly where public market access could fund expansion more effectively than additional private financing, or where national security considerations limit potential buyers.

Even if an IPO is not the expected exit, it is prudent for companies to develop the financial reporting, governance and compliance infrastructure required for one, as that readiness can help secure a materially better valuation and accelerate the sale process.

Preparation should start well before a sale process begins:

  • IP ownership should be documented, including rights from founders, employees, contractors, university relationships and development partners.
  • Government contracts and grants should be reviewed for applicable restrictions.
  • The company should know which third-party consents, change-of-control provisions or liens could affect a transaction.

A strategic sale can be an attractive alternative, especially when a buyer (particularly a defense contractor, industrial company or technology business) is able to acquire specialized engineering teams, proprietary technology, manufacturing capabilities or access to an emerging market well before a product reaches full commercial deployment. In some cases, the buyer can accelerate development by integrating the acquired business into its own customer, manufacturing or distribution platforms.

A strategic sale can also allow founders and investors to realize value earlier than under a stand-alone public company strategy, and it changes the financing calculus. A credible sale path may reduce how much capital, and how much dilution, a company needs to take on, since the buyer can fund scale-up. Capital that carries the company to a meaningful technical or commercial milestone can increase strategic value, but excessive leverage or restrictive financing terms can complicate the sale itself.

That said, buyers of early-stage technology businesses must be clear about what they are actually purchasing. The value often lies less in current revenue than in IP, personnel, technical know-how, customer relationships, contracts or the ability to build a product faster than the buyer could alone.

Diligence should go beyond conventional financial metrics. Technical feasibility, product maturity, IP ownership and transferability, regulatory compliance, contract rights, supply chain dependencies and retention of key personnel can all drive value, as can the successful integration of the target’s technology without disruption to customer relationships or government programs.

The deal structure matters as well. Stock or asset purchases, milestone-based or contingent consideration, earnouts and retention arrangements can all help allocate risks and uncertainty, but each approach raises distinct questions of valuation, financing, tax, liability allocation, regulatory approvals and the treatment of existing debt, among others.

Capital Strategy and Exit Strategy Should Be Developed Together

Today’s financing decision can shape tomorrow’s strategic options, and the appeal of debt is straightforward: Unlike an equity issuance, borrowing does not require founders and existing stockholders to surrender ownership.

But avoiding dilution does not always mean avoiding economic cost or strategic constraints, and the terms of a financing can follow a company into its next transaction:

  • A lender’s liens may need to be released or restructured in a sale.
  • Change-of-control provisions may require lender or investor consent, or trigger debt repayment.
  • Investor approval rights may limit new financing or a strategic transaction.
  • Government program requirements may influence the timing, structure or feasibility of an acquisition or new investment.

These issues are best considered before financing documents are signed, with an exit strategy as part of the plan from the start. Founders, boards and investors should consider looking beyond immediate funding needs to the next financing, likely strategic partners and potential exit paths.

The same holds true in reverse. Lenders and investors that understand a company’s likely buyers, contract profile and regulatory environment get a more complete picture of risk, repayment prospects and long-term value. Acquirers that understand a target’s capital structure, investor rights and contractual obligations early can identify execution risks before they become obstacles to closing.

What Companies Should Consider Now

Founders, executives and boards can consider taking practical steps now to prepare for the next stage of growth:

  • Perform a comprehensive review of the capitalization table.
  • Understand investor and lender dynamics, including the rights that existing investors and lenders have in future financing and strategic scenarios, as well as where consents may be needed, where rights may conflict or where execution risk may arise.
  • Map financing needs to milestones.
  • Understand the current financing market, what is available, and the full costs and benefits of different types of financing.
  • Balance future financing and strategic flexibility against current, more immediate needs for funds.
  • Anticipate what may be required for government and regulatory diligence, if government programs are a consideration.
  • Keep exit options in mind.

Associates Blake H. Bainou and Harrison Meads contributed to this client alert.

This memorandum is provided by Skadden, Arps, Slate, Meagher & Flom LLP and its affiliates for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

BACK TO TOP